Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Jazz Pharmaceuticals (JAZZ) Q3 2025 Earnings
JAZZ
5
Aug
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-8.25
-3.3
1.66
6.61
Details
Expected EPS
-7.606016
Actual EPS
-8.25
Surprise EPS
-0.64
Surprise Percent
+8.47%
Description
Jazz Pharmaceuticals (JAZZ) has reported earnings of -8.25 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login